Dr Reddy's Labs to acquire select anti-allergy brands of Glenmark
The acquired brands represent two types of products, mometasone mono product and combination of mometasone with azelastine, which are indicated for the treatment of seasonal and perennial allergic rhinitis, Dr Reddy's added.;
New Delhi: Dr Reddy's Laboratories on Saturday said it has inked a pact with Glenmark Pharmaceuticals to acquire its select anti-allergy brands in Russia, Ukraine, Kazakhstan and Uzbekistan.
The Hyderabad-based company has entered into a definitive agreement with Glenmark to acquire brands Momat Rino (for Russia, Kazakhstan and Uzbekistan), Momat Rino Advance (for Russia), Momat A (for Kazakhstan and Uzbekistan), Glenspray and Glenspray Active (for Ukraine), along-with rights to the trademarks, dossiers and patents for the territories mentioned, Dr Reddy''s Laboratories said in a statement.
The acquired brands represent two types of products -- mometasone mono product and combination of mometasone with azelastine, which are indicated for the treatment of seasonal and perennial allergic rhinitis, it added.
The company however did not disclose financial details.
"The new brands are a great addition to our product portfolio in Russia, Ukraine, Kazakhstan and Uzbekistan which are important core markets for us. Momat Rino, the largest brand acquired, has recently received OTC registration in Russia and this will enable accelerated access of this product to patients," Dr. Reddy''s Laboratories Branded Markets (India and Emerging Markets) CEO M V Ramana said.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.